Welcome to RE Assist
* indicates pediatric indication
| Vaccines | |||||
| ABRYSVO™ Respiratory Syncytial Virus Vaccine (for Vaccines*) |
|||||
| COMIRNATY®(COVID-19 Vaccine, mRNA)2024-2025 FORMULA (for Vaccines* and Vaccine: COVID 19*) |
|||||
| PAXLOVID™ nirmatrelvir tablets; ritonavir tablets
(for coronovirus) |
|||||
| PENBRAYA™ Meningococcal Groups A, B, C, W, and Y Vaccine (for Vaccines*) |
|||||
| PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine)
(for Vaccines*) |
|||||
| TRECATOR®
(for Tuberculosis) |
|||||
| TRUMENBA® (Pneumococcal 20-valent Conjugate Vaccine)
(for Vaccines*) |
|||||
| Oncology | |||||
| ADCETRIS®
(for Hodgkin's Lymphoma* and Non-Hodgkin's Lymphoma*) |
|||||
| AROMASIN
(for Breast Cancer and Ovarian Cancer) |
|||||
| BESPONSA™ (inotuzumab ozogamicin) injection for IV infusion 0.9 mg single-dose vial
(for Acute lymphoblastic leukemia*) |
|||||
| BOSULIF® (bosutinib) tablets
(for Chronic Myeloid Leukemia) |
|||||
| BRAFTOVI® 75 mg capsules
(for Melanoma, NSCLC and Colorectal Cancer)(encorafenib) |
|||||
| CAMPTOSAR®
(for Colorectal Cancer) |
|||||
| DAURISMO™ (encorafenib) 75 mg capsules
(for Acute lymphoblastic leukemia*) |
|||||
| ELLENCE®
(for Breast Cancer) |
|||||
| ELREXFIO™ (elranatamab-bcmm)
Injection for subcutaneous use | 44 mg 1.1 mL, 76 mg 1.9 mL
(for Multiple Myeloma) |
|||||
| IBRANCE® (palbociclib) capsules
(for Breast Cancer) |
|||||
| IDAMYCIN®
(for Acute Myeloid Leukemia*) |
|||||
| INLYTA® (axitinib) tablets
(for Renal Cell Carcinoma) |
|||||
| LORBRENA® (lorlatinib) tablets
(for NSCLC) |
|||||
| MEKTOVI® (binimetinib) 15mg tablets
(for Melanoma and NSCLC) |
|||||
| MYLOTARG™ (gemtuzumab ozogamicin) INJECTION FOR IV INFUSION 4.5 mg single-dose vial
(for Acute Myeloid Leukemia*) |
|||||
| RUXIENCE® (rituximab-pvvr) injection
(for Non-Hodgkin's Lymphoma* and Chronic Lymphocytic Leukemia) |
|||||
| SUTENT® (sunitinib malate) capsules
(for Renal Cell Carcinoma, Pancreatic Cancer and gastrointestinal stromal tumor (GIST)) |
|||||
| TALZENNA® (talazoparib) capsules
(for Breast Cancer and Prostate Cancer) |
|||||
| TIVDAK®
(for Cervical Cancer) |
|||||
| TRAZIMERA® (trastuzumab-qyyp)
(for Breast Cancer and Gastric Cancer) |
|||||
| TUKYSA®
(for Breast Cancer and Colorectal Cancer) |
|||||
| VIZIMPRO® (dacomitinib) tablets
(for NSCLC) |
|||||
| XALKORI® (crizotinib) Capsules
(for Non-Hodgkin's Lymphoma*, NSCLC and inflammatory myofibroblastic tumor (IMT)) |
|||||
| ZIRABEV® (bevacizumab-bvzr) injection
(for Colorectal Cancer) |
|||||
| Autoimmune Disorders | |||||
| ABRILADA™ (adalimumab-afzb)
(for Psoriatic Arthritis, Rheumatoid Arthritis, Crohn's Disease*, Ankylosing Spondylitis, Ulcerative Colitis, Polyarticular Course Juvenile Idiopathic Arthritis, Plaque Psoriasis, Hidradenitis Suppurativa, and Uveitis) |
|||||
| CIBINQO™ Abrocitinib
(for Atopic Dermatitis*) |
|||||
| EUCRISA™ (crisaborole) ointment, 2%
(for Atopic Dermatitis*) |
|||||
| LITFULO™ (ritlecitinib) 50mg capsules
(for alopecia areata*) |
? | ||||
| RUXIENCE® (rituximab-pvvr) injection
(for Rheumatoid Arthritis and Microscopic Polyangiitis (MGA) Granulomatosis with Polyangiitis (GPA)) |
|||||
| VELSIPITY™ (etrasimod) 2 mg tablets
(for Ulcerative Colitis) |
|||||
| XELJANZ® (tofacitinib) tablets/XELJANZ® XR (tofacitinib) extended release tablets
(for Psoriatic Arthritis, Rheumatoid Arthritis, Ankylosing Spondylitis, Ulcerative Colitis, and Polyarticular Course Juvenile Idiopathic Arthritis) |
|||||
| Endocrinology | |||||
| GENOTROPIN® (somatropin) for injection
(for Growth Hormone Deficiency*, Prader-Willi syndrome (pediatric)*, Small for Gestational Age (pediatric)*, Turner syndrome (pediatric)* and Idiopathic Short Stature (pediatric)*) |
|||||
| NGENLA™ (somatrogon-ghla) injection
(for Growth Hormone Deficiency*) |
|||||
| SOMAVERT® (pegvisomant for injection)
(for Acromegaly) |
|||||
| SYNAREL®
(for Central Precocious Puberty (CPP)*) |
|||||
| Blood Disorders including Hemophilia | |||||
| BENEFIX® Coagulation Factor IX (Recombinant)
(for Hemophilia B) |
|||||
| ELELYSO™ (taliglucerase alfa) for injection
(for Hemophilia B) |
|||||
| HYMPAVZI™ (marstacimab-hncq)
(for Hemophilia A and Hemophilia B) |
|||||
| NIVESTYM® (filgrastim-aafi) injection, for subcutaneous or intravenous use
(for neutropenia) |
|||||
| NYVEPRIA® (pegfilgrastim-apgf)
(for neutropenia) |
|||||
| RETACRIT® (epoetin alfa-epbx) for injection
(for Anemia) |
|||||
| XYNTHA®
(for Hemophilia A) |
|||||
| Migraine | |||||
| CELONTIN®
(for Absence Seizures) |
|||||
| NURTEC® (rimegepant) orally disintegrating tablets 75mg
ODT (for migraine) |
|||||
| ZARONTIN®
(for Absence Seizures) |
|||||
| ZAVZPRET™ (zavegepant) nasal spray 10mg
(for migraine) |
|||||
| Cardiology | |||||
| NORPACE®
CR (for ventricular arrhythmias) |
|||||
| TIKOSYN® (dofetilide) Capsules
(for irregular heartbeat) |
|||||
| VYNDAMAX® (tafamidis) capsules
(for irregular heartbeat) |
|||||
| VYNDAQEL® (tafamidis meglumine) capsules
(for irregular heartbeat) |
|||||
| Rare Genetic Disorders | |||||
| BENEFIX® Coagulation Factor IX (Recombinant)
(for Hemophilia B) |
|||||
| ELELYSO™ (taliglucerase alfa) for injection
(for Hemophilia B) |
|||||
| HYMPAVZI™ (marstacimab-hncq)
(for Hemophilia A and Hemophilia B) |
|||||
| Women's Health | |||||
| DEPO® Estradiol
(for Symptoms of Menopause) |
|||||
| DUAVEE™ (conjugated estrogens/bazedoxifene) 0.45 MG/20 MG Tablets
(for Symptoms of Menopause and postmenopausal osteoporosis) |
|||||
| ESTRING® (estradiol vaginal system)
(for Symptoms of Menopause) |
|||||
| PREMARIN®
(for Symptoms of Menopause, Atrophic Vaginitis and postmenopausal osteoporosis) |
|||||
| PREMPHASE®
(for Symptoms of Menopause and postmenopausal osteoporosis) |
|||||
| PREMPRO®
(for Symptoms of Menopause and postmenopausal osteoporosis) |
|||||
| SYNAREL®
(for endometriosis) |
|||||
| Rheumatoid Arthritis | |||||
| ABRILADA™ (adalimumab-afzb)
(for Psoriatic Arthritis, Rheumatoid Arthritis, Crohn's Disease*, Ankylosing Spondylitis, Ulcerative Colitis, Polyarticular Course Juvenile Idiopathic Arthritis, Plaque Psoriasis, Hidradenitis Suppurativa, and Uveitis) |
|||||
| INFLECTRA® (infliximab-dyyb) for injection
(for Psoriatic Arthritis and Rheumatoid Arthritis) |
|||||
| RUXIENCE® (rituximab-pvvr) injection
(for Rheumatoid Arthritis and Microscopic Polyangiitis (MGA) Granulomatosis with Polyangiitis (GPA)) |
|||||
| XELJANZ® (tofacitinib) tablets/XELJANZ® XR (tofacitinib) extended release tablets
(for Psoriatic Arthritis, Rheumatoid Arthritis, Ankylosing Spondylitis, Ulcerative Colitis, and Polyarticular Course Juvenile Idiopathic Arthritis) |
|||||
Last Updated: 12/05/2025 10:29pm